Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.covid19.nih.gov/
NIH staff guidance on coronavirus (NIH Only): https://employees.nih.gov/pages/coronavirus/
- Home
- About NICHD
- Organization
- Division of Extramural Research (DER)
- Extramural Scientific Branches
- Intellectual and Developmental Disabilities Branch (IDDB)
- Branch-Specific Funding Opportunities and Notices
IDDB Funding Opportunities and Notices
NICHD publishes and participates in various Funding Opportunity Announcements (FOAs) and NIH Guide Notices (NOTs) to support research and training activities. The following table includes branch-specific FOAs, sorted by date from most recent to older. Select a table heading to change how the information is sorted.
A listing of NICHD-specific NOTs is available on the Active FOAs and NOTs page.
Please note: the following are sorted alphabetically by announcement number. Select a table heading to change how the information is sorted.
Announcement Number | Submissions Date(s) | Expiration Date | Activity Code(s) | Title |
---|---|---|---|---|
RFA-HD-21-008 | December 3, 2020 | December 4, 2020 | U24 | Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project (U24 Clinical Trial Not Allowed) |
RFA-HD-21-009 | August 14, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
August 15, 2020 | P50 | Intellectual and Developmental Disabilities Reserch Centers [IDDRC] FY 2021 (P50 Clinical Trial Optional) |
PAR-20-101 | May 27, 2020, May 27, 2021, May 27, 2022, | May 27, 2022 | U24 | Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) |
RFA-HD-20-003 | July 4, 2020 | P50 | Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional) | |
RFA-HD-20-016 | January 15, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 16, 2020 | P50 | Intellectual and Developmental Disabilities Research Centers 2019 (P50 - Clinical Trial Optional) |
RFA-MH-20-325 | January 9, 2020 All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement. |
December 24, 2019 | U19 | Limited Competition: Consortium on Biomarker and Outcome Measures of Social Impairment for Use in Clinical Trials in Autism Spectrum Disorder (U19 Clinical Trial Not Allowed) |
PAR-19-376 | November 19, 2019; September 24, 2020 | December 4, 2020 | R21/R33 | Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) |
RFA-NS-19-031 | October 31, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
November 1, 2019 | P50 | Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50) |
PAR-18-766 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
September 8, 2021 | R01 | Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 - Clinical Trial Optional) |